COVID-19
Conditions
Interventions
None listed
Sponsors
Kanagawa Physicians Association
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who regularly visit medical institutions belonging to the Kanagawa Physicians Association or physicians and nurses employed at those institutions 2) All ages eligible 3) Those who are living in Japan and can participate in continuous follow-ups 4) Those who consent to participate in the study (in the case of minors, consent should be obtained from their legal guardian)
Exclusion criteria
Exclusion criteria: 1) Those who have tested positive for SARS-CoV-2 2) Those who had cold-like symptoms such as a fever within the past 21 days 3) Those who had cold-like symptoms and/or a fever of 37.5 degrees or more for at least four days in 2020 4) Those who had extreme fatigue and/or dyspnea in 2020
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SARS-CoV-2 positivity rate in IgG antibody tests | — |
Secondary
| Measure | Time frame |
|---|---|
| Rates of SARS-CoV-2-positive patients in IgG antibody tests for different elements of patient backgrounds SARS-CoV-2 positivity rate in IgG antibody tests (2,4 and 6 month after being found to be positive) Clinical symptoms (2,4,6 and 12 month after being found to be positive) SARS-CoV-2 positivity rate in IgG antibody tests in the doctor/nurse group (in 2021) | — |
Countries
Japan
Contacts
Public ContactIkuro Matsuba
Kanagawa Physicians Association Scientific Committee
Outcome results
None listed